Drug interaction between lenalidomide and itraconazole.
Naoto
N
Takahashi
Masatomo
M
Miura
Yoshihiro
Y
Kameoka
Maiko
M
Abumiya
Kenichi
K
Sawada
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors; D019072:Antibiotic Prophylaxis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019540:Area Under Curve; D051544:Cytochrome P-450 CYP3A; D065692:Cytochrome P-450 CYP3A Inhibitors; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D017964:Itraconazole / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000077269:Lenalidomide; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced*; D011241:Prednisone / Q000008:administration & dosage; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D065692:Cytochrome P-450 CYP3A Inhibitors; D017964:Itraconazole; D013792:Thalidomide; D003907:Dexamethasone; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D000077269:Lenalidomide; D008558:Melphalan; D011241:Prednisone